Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 19.06
+0.36 (1.93%)
Jun 10, 2026, 4:00 PM EDT
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 9.69 billion as of June 10, 2026. Its market cap has decreased by -3.49% in one year.
Market Cap
9.69B
Enterprise Value
9.54B
Revenue
679.75M
Ranking
n/a
PE Ratio
377.35
Stock Price
19.06
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 9.69B, an increase of 17.28%. That is a compound annual growth rate of 3.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 9.69B | -21.10% |
| Dec 31, 2025 | 12.28B | 93.40% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Hisun Pharmaceutical | 10.98B |
| Zhejiang Jiuzhou Pharmaceutical | 10.89B |
| Hubei Hongyuan Pharmaceutical Technology | 10.87B |
| Shenzhen Chipscreen Biosciences | 10.85B |
| Zhejiang CONBA Pharmaceutical | 10.48B |
| Yantai Dongcheng Pharmaceutical Group | 10.30B |
| Zhejiang Jingxin Pharmaceutical | 10.25B |
| Mayinglong Pharmaceutical Group | 10.05B |